Compact accelerator-based production of carrier-free 177Lu from 18 MeV $$D^+$$ D + on [176Yb] $$\hbox {Yb}_2\hbox {O}_3$$ Yb 2 O 3
Abstract Background Recent EMA and FDA approvals of Lu-DOTATATE and Lu-PSMA-617 have led to increased demand for radiotherapeutic $$^{177}$$ 177 Lu, due to its promising potential to treat castration-resistant neuroendocrine cancers. Conventional reactor production methods pose challenges related to...
Guardat en:
| Autors principals: | , , , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
SpringerOpen
2025-08-01
|
| Col·lecció: | EJNMMI Radiopharmacy and Chemistry |
| Matèries: | |
| Accés en línia: | https://doi.org/10.1186/s41181-025-00358-3 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|